Autopsy report · NCT06985342

Acute Migraine Treatment in the ED With Gepants

“Study closing at current site. Study to start as new at different site.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 8 months before it stopped.
• 9 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Icahn School of Medicine at Mount Sinai

Sponsor type

University, hospital or other

Conditions

Migraine Headaches

Interventions

Rimegepant; Zavegepant

Participants

9

Sites

1

Countries

United States

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.